Sage CEO hopes for a Prozac moment with experimental depression drug
December 08, 2017 at 13:33 PM EST
Sage Therapeutics CEO Jeff Jonas hopes a drug in development for major depressive disorder will be as big as Prozac.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.